Press Releases and Statements

Browse Press Releases and Statements Content

CHPA’s President and CEO, Scott Melville, today released the following statement in response to the FDA releasing a proposed rule on "Nonprescription Drug Product with an Additional Condition for Nonprescription Use" (ACNU):

Jun 27, 2022

The Consumer Healthcare Products Association (CHPA) today announced the hiring of Larisa Pavlick as its new Senior Director of Quality Assurance and Technical Affairs and Kirby Miller as its new Director of Federal Government Affairs.

Jun 21, 2022

CHPA’s Senior Vice President of Dietary Supplements, Duffy MacKay, ND, released the following statement in response to the U.S. Preventive Services Task Force (USPSTF) updated recommendation on vitamins, minerals, and multivitamin supplements

Jun 21, 2022

The Consumer Healthcare Products Association (CHPA) today announced Lisa Paley as Chair-Elect of the CHPA Board of Directors. Paley will assume the position of Board Chair in March 2023, when current CHPA Board Chair Michelle Goodridge, President, U.S. Self Care, Johnson & Johnson Consumer, Inc. concludes her chairmanship.

Jun 17, 2022

CHPA’s President and CEO Scott Melville released the below statement today following the Senate HELP Committee’s Markup of S.4348, the FDA Safety and Landmark Advancement (FDASLA) Act of 2022:

Jun 14, 2022

Awareness of acetaminophen safe use and the risks of using too much remains high, indicating that ongoing education is critical to continued progress.

Jun 6, 2022

The Consumer Healthcare Products Association (CHPA) issued a statement from Duffy MacKay, Senior Vice President of Dietary Supplements, regarding a report from the U.S. Centers for Disease Control and Prevention (CDC) on Pediatric Melatonin Ingestions—United States, 2012-2021.

Jun 3, 2022

CHPA’s President and CEO, Scott Melville, released a statement in response to the introduction of the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 27, 2022

CHPA’s President & CEO, Scott Melville, released a statement in response to the FDA Safety and Landmark Advancement (FDASLA) Act of 2022.

May 18, 2022

CHPA has issued a statement in response to a recent, observational NSAID study published in the journal Science Translational Medicine.

May 17, 2022

The Consumer Healthcare Products Association (CHPA) today announced the hiring of Logan Tucker as Director of Communications and Media Relations.

May 2, 2022

CHPA President and CEO Scott Melville released a statement in response to Senator Durbin’s and Senator Braun’s Introduction of the Dietary Supplement Listing Act of 2022.

Apr 26, 2022

Filter Results